The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCINE.L Regulatory News (CINE)

  • There is currently no data for CINE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Covenant amendments and additional liquidity

28 May 2020 07:00

RNS Number : 1438O
Cineworld Group plc
28 May 2020
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

28 May 2020

 

Cineworld Group plc ("Cineworld" or the "Group")

Covenant amendments and additional liquidity secured

 

Cineworld is pleased to announce that its lenders have agreed to waive the leverage covenant1 in respect of its credit facility for the June 2020 testing date and has increased its leverage covenant1 to 9.0x Net Debt to EBITDA for the December 2020 testing date.

The Group has also agreed the terms of $110m of additional liquidity through an increase in its revolving credit facility. In addition, the Company has secured credit committee approval to apply for an additional $45m through the CLBILS loan scheme in the UK and expects shortly to commence a process to access $25m through the US government CARES Act. Cineworld expects that this additional liquidity, to the extent required, will provide it with sufficient headroom to support the Group even in the unlikely event cinemas remain closed until the end of the year.

Cineworld currently anticipates that government restrictions related to cinemas will be lifted in each of its territories by July. Subject to this and confirmation of the schedule for film releases, Cineworld anticipates the reopening of all of its cinemas in July. Cineworld has put in place procedures to ensure a safe and enjoyable cinema experience for its employees and customers.

Cineworld is excited by the great movie line up to follow the reopening of cinemas, starting with the highly anticipated new Chris Nolan movie Tenet and immediately after that with Mulan, a new Disney adventure movie.

Cineworld, as always, greatly believes in the theatrical experience and is fully committed to be the best place to watch a movie.

Note 1: The revolving credit facility has a leverage covenant triggered above 35% utilisation, tested at half year and full year on a trailing twelve-month basis. The next covenant test has been waived, with the next test occurring on 31 December 2020. At 31 December 2020, the leverage covenant requires Net Debt to EBITDA of below 9.0x on a pre-IFRS 16 basis. At 30 June 2021, the leverage covenant requires Net Debt to EBITDA of below 5.5x and reduces to 5.0x from 31 December 2021 onwards.

Contacts:

Israel GreidingerNisan CohenManuela Van Dessel

 

+44 (0) 20 8987 5000

investors@cineworld.co.uk

James Leviton

Andy Parnis

Rob Allen

 

+44 (0) 20 7251 3801

cineworld-lon@finsbury.com

The person responsible for arranging the release of this announcement is Fiona Smith, Company Secretary.

Certain statements in this announcement are forward looking and so involve risk and uncertainty because they relate to events, and depend upon circumstances that will occur in the future and therefore results and developments can differ materially from those anticipated. The forward looking statements reflect knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCSEWEFWESSESI
Date   Source Headline
31st Aug 202212:42 pmRNSStandard form for notification of major holdings
31st Aug 202211:37 amRNSResponse to press commentary
30th Aug 20222:30 pmRNSStandard form for notification of major holdings
26th Aug 20224:41 pmRNSSecond Price Monitoring Extn
26th Aug 20224:36 pmRNSPrice Monitoring Extension
25th Aug 20221:44 pmRNSStandard form for notification of major holdings
25th Aug 202210:00 amRNSStandard form for notification of major holdings
24th Aug 20224:40 pmRNSSecond Price Monitoring Extn
24th Aug 20224:35 pmRNSPrice Monitoring Extension
24th Aug 20224:15 pmRNSStandard form for notification of major holdings
24th Aug 202210:00 amRNSStandard form for notification of major holdings
22nd Aug 20222:00 pmRNSHolding(s) in Company
22nd Aug 20227:00 amRNSResponse to media speculation
17th Aug 20227:00 amRNSUpdate on trading, liquidity and capital structure
10th Jun 20225:15 pmRNSNotice of Interim Results
31st May 20229:00 amRNSTotal Voting Rights
24th May 20229:00 amRNSStandard form for notification of major holdings
20th May 20229:00 amRNSBlock Listing Application
12th May 20223:20 pmRNSResults of Annual General Meeting
10th May 20227:00 amRNSUpdate on Regal dissenting shareholders agreement
9th May 20229:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
4th May 20227:00 amRNSUpdate on Regal dissenting shareholders agreement
7th Apr 20224:00 pmRNSAnnual Report and Notice of Annual General Meeting
17th Mar 20227:00 amRNSPreliminary Results
25th Feb 20222:30 pmRNSStandard form for notification of major holdings
18th Feb 20227:04 amRNSUpdate on Regal Dissenting Shareholders Agreement
1st Feb 20227:00 amRNSUpdate on Regal dissenting shareholders agreement
28th Jan 20227:00 amRNSCineworld Group plc Cineplex Inc. Litigation
14th Jan 20224:30 pmRNSCommittee Changes
14th Jan 20227:00 amRNSCineworld Group plc Trading Update
15th Dec 20217:00 amRNSUpdate on Cineplex Inc. litigation
15th Nov 20217:00 amRNSTrading Update
9th Nov 20212:45 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Nov 20212:45 pmRNSStandard form for notification of major holdings
27th Sep 20212:45 pmRNSHolding(s) in Company
12th Aug 20217:00 amRNSInterim Results for the period ended 30 June 2021
30th Jul 20217:00 amRNSFurther Liquidity and Covenant Flexibility Secured
24th Jun 20216:00 pmRNSDirector Declaration
10th Jun 202110:54 amRNSDirector Declaration
24th May 20217:00 amRNSCompany Update
20th May 20212:00 pmRNSHolding(s) in Company
14th May 20216:31 pmRNSRegal Dissenting Shareholders Claim
12th May 20213:00 pmRNSResults of Annual General Meeting
10th May 20213:00 pmRNSBlock listing Interim Review
4th May 20212:00 pmRNSTotal Voting Rights
26th Apr 20212:00 pmRNSHolding(s) in Company
26th Apr 20218:00 amRNSBlock Listing Application
22nd Apr 20213:45 pmRNSHolding(s) in Company
15th Apr 20215:00 pmRNSDirector/PDMR Shareholding
13th Apr 20213:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.